• Application Note

Fast and Sensitive Quantitative LC-MS/MS Methods in Bioanalysis: HPLC versus UPLC

Fast and Sensitive Quantitative LC-MS/MS Methods in Bioanalysis: HPLC versus UPLC

  • Iain Gibb
  • Ed Sprake
  • Steve Preece
  • Erin McManus
  • Diane M. Diehl
  • Waters Corporation
Variety of medicines and drugs

This is an Application Brief and does not contain a detailed Experimental section.

Abstract

This application brief demonstrates the benefits of UPLC compared to traditional HPLC for the analysis of risperidone, 9-hydroxyrisperidone, and the internal standard, clozapine.

Introduction

HPLC-MS/MS is a widely utilized technique for quantitative bioanalysis due to its sensitivity and selectivity. There are three main challenges that face LC-MS/MS when developing new methods these are:

  • Speed
  • Sensitivity
  • Resolution

Waters solution to the above challenges is the ACQUITY UltraPerformance LC System.

Experimental

HPLC Conditions

HPLC system:

Waters Alliance HT System

Column:

Xterra MS C18, 2.1 x 50 mm, 3.5 μm

Mobile phase A:

2 mM CH3COO–NH4+in H2O, pH 9.0

Mobile phase B:

Methanol

Flow rate:

0.3 mL/min

Injection volume:

5 μL

Sample diluent:

0:50 v/v Methanol:Water

Column temp.:

50 °C

Total run time:

5.5 min.

Gradient

Time (min)

A%

B%

Curve

0.0

50

50

-

0.5

50

50

6

2.0

0

100

6

2.5

50

50

11

UPLC Conditions

UPLC system:

Waters ACQUITY UPLC System

Column:

ACQUITY UPLC BEH C18, 2.1 x 50 mm, 1.7 μm

Mobile phase A:

2 mM CH3COO–NH4+in H2O, pH 9.0

Mobile phase B:

Methanol

Flow rate:

0.6 mL/min

Injection volume:

5 μL

Sample diluent:

50:50 v/vMethanol:Water

Column temp.:

50 °C

Total run time:

1.5 min

Gradient

Time (min)

A%

B%

Curve

0.00

50

50

-

0.25

50

50

6

0.75

0

100

6

1.25

50

50

11

MS Conditions

MS system:

Waters Micromass Quattro Premier XE

Ionization mode:

Positive Ion Electrospray (ESI+)

Capillary voltage:

3.00 V

Desolvation temp.:

380 °C

Desolvation gas flow:

800 L/hr

Cone gas flow:

50 L/hr

Collision cell pressure:

3.50e–3

MRM transitions:

Dwell Time: 30 ms for all transitions

Inter-Scan Delay: 10 ms for all transitions

Results and Discussion

Speed and Resolution

The UPLC method that was developed resulted in a 70% decrease inanalysis time compared to HPLC (Figure 1) with no significant change in chromatographic resolution (Figure 2), allowing a three-fold increase in sample throughput. The gradient and flow rates were optimized for both HPLC and UPLC and the reduction in analysis time results partly from the use of these conditions with the UPLC column, and partly to the very low system volume in the UPLC hardware. This low system volume also has a benefit in reducing the time required for equilibration when gradient elution is used, therefore further increasing sample throughput and allowing the efficient use of MS/MS. 

Risperidone, 9–OH Risperidone, and Clozapine (internal standard) run time, HPLCvs. UPLC
Risperidone, 9-OH Risperidone, and Clozapine resolution, HPLC vs. UPLC
Figure 2. Risperidone, 9-OH Risperidone, and Clozapine resolution, HPLC vs. UPLC. 

Sensitivity

The narrow peak widths produced by the UPLC, typically 2–3 seconds wide at base, result in increased peak intensity and improved signal-to-noise ratios. This allows lower limits of quantification (LLOQ) to be reached compared to HPLC. In this example (Figures 3 and 4), a 3-fold increase in the signal-to-noise was achieved for a 0.1 ng/mL LLOQ. 

Risperidone sensitivity, HPLC vs. UPLC
Figure 3. Risperidone sensitivity, HPLC vs. UPLC. 
9–OH Risperidone sensitivity, HPLC vs. UPLC
Figure 4. 9-OH Risperidone sensitivity, HPLC vs. UPLC. 

Conclusion

UPLC allows the development of fast and sensitive LC-MS/MS methods. When compared to conventional HPLC, significant reductions in analysis time and lower limits of quantification can be achieved, without the need to change the sample preparation method or the MS/MS system being used. In this example, a three-fold increase in both throughput and sensitivity was gained using the ACQUITY UPLC System. 

720001443, December 2005

Back To Top Back To Top